| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 1995;26:1527-1530.)
© 1995 American Heart Association, Inc.
Articles |
From the Department of Neurology, Boston University School of Medicine (H.-J.L., P.A.W.); Cardiology Section, Boston City Hospital, Boston University School of Medicine (E.J.B.); Department of Mathematics, Boston University (A.J.B., R.B.D'A.); and the Framingham Study, National Heart, Lung, and Blood Institute, Framingham, Mass.
| Abstract |
|---|
|
|
|---|
Methods The Framingham Study cohort of 5070 members, aged 30 to 62 years and free of cardiovascular disease at entry, has been under surveillance for the development of cardiovascular disease, including stroke. We followed the course of AF, which was documented for the first time on or soon after hospital admission for stroke.
Results During 38 years of follow-up, 115 of 656 initial stroke events occurred in association with AF: 89 had previously documented AF, 21 had AF discovered for the first time on admission for the stroke, and 5 were admitted with sinus rhythm but developed AF after admission. Of the 21 subjects with AF diagnosed on admission, in 12 (57%) AF persisted thereafter (chronic AF). Among the other 9 persons presenting with nonpersistent AF, paroxysms recurred in 3 (14%) and became chronic AF in 4 (19%). AF was transient and did not recur in only 2 persons (10%). Of the 5 subjects who developed AF after admission, AF was sustained from the initial diagnosis in 2 and recurred in paroxysms or became established as chronic in 3.
Conclusions Ninety-two percent (24/26) of subjects presenting with newly discovered AF at the time of acute stroke continued to have this rhythm disturbance in a chronic or paroxysmal form. In only 2 subjects (8%) was the arrhythmia short-lived and nonrecurrent. These follow-up data suggest that in most instances AF was probably the precipitant rather than the consequence of stroke.
Key Words: atrial fibrillation risk factors stroke onset
| Introduction |
|---|
|
|
|---|
| Subjects and Methods |
|---|
|
|
|---|
AF was identified both at the time of biennial examination and on interim hospitalizations and outside examinations. Onset was considered to be the time of the first documentation on ECG without prior history of AF. For those subjects in whom AF was discovered for the first time on admission for stroke or during the acute hospital stay, the course of AF was sought by scrutiny of ECGs and all available medical information, including interim hospitalizations, records of drugs used to control AF, data from visits to physicians, and routine biennial examinations. All AF ECGs were reviewed and verified by a cardiologist. Chronic AF was defined as AF that persisted from the initial diagnosis. When there was reversion to sinus rhythm, AF was considered paroxysmal. According to the pattern, paroxysmal AF could be either transient for one single episode only or recurrent for more than one episode.
| Results |
|---|
|
|
|---|
|
|
Of the 21 subjects with acute stroke who were discovered for the first
time to have AF on admission, 57% (12/21) continued thereafter to be
in AF. In the other 9 subjects AF reverted to sinus rhythm; in 7 of
them AF recurred in either a chronic (n=4) or paroxysmal (n=3) form. AF
was transient and nonrecurrent in only 2 subjects (Table 2
and Figure
), 1 of whom presented with a
primary cerebellar hemorrhage and was the only patient with
hemorrhagic stroke among subjects with newly diagnosed AF.
|
Among the 5 subjects with first AF documentation 2 to 14 days after
admission, AF was sustained from the initial diagnosis (n=2) or
recurred in later course (n=3) (Table 2
and Figure
).
| Discussion |
|---|
|
|
|---|
Investigations on the time course of AF for embolic complications have demonstrated that the risk of stroke in subjects with AF seems highest during the early months after the initial diagnosis of AF.8 9 10 15 This distinct clustering of strokes can be seen in both chronic AF9 10 and paroxysmal AF,8 as well as immediately after transition from paroxysmal AF to chronic AF.8 It has been suggested that this clustering of thromboembolic complications should be taken into consideration when patients with AF are evaluated for stroke prevention.8 10 11
On the other hand, numerous studies have described a variety of cardiac arrhythmias including AF associated with acute stroke.16 17 18 19 20 21 22 23 24 25 While any attempt to attribute the onset of cardiac arrhythmia to acute stroke should exclude the alternative possibility of preexisting cardiac diseases, only a few studies have included comparisons with prior history to document that the AF associated with acute stroke actually was new.16 17 18 21 23 24 In these studies AF was found in 4% to 7% of subjects with subarachnoid hemorrhage23 24 26 and in 3% to 9% of those with other types of stroke.16 17 18 21 However, the causal relationship between stroke and AF was seldom discussed in detail. The report of Vingerhoets et al13 was the first study to specifically address the hypothesis that some patients with acute stroke might develop transient AF as a consequence of the stroke. They compared 41 subjects with newly diagnosed AF during hospitalization for stroke, including 24 with AF at the time of admission and 17 with AF soon after admission, to stroke subjects with prior history of AF (n=144) or with another cardioembolic source (n=332). A higher frequency of primary hematoma (9.8% versus 2.8% and 0.9%) and more involvement of parietoinsular and brain stem areas were seen in the subjects with newly diagnosed AF. The AF described was generally transient and rarely recurred, a finding that was based on observations during acute hospitalization (23 days on average; range, 3 to 77 days) and considered evidence of cerebral arrhythmogenicity. Nevertheless, in view of the fact that many persons with chronic AF experience this arrhythmia intermittently before it becomes established, follow-up data after stroke would be essential in addressing the significance of "transient" AF at the acute stage of stroke. Unfortunately, such information was not generally available in these studies.
In the present study we approached this issue by scrutinizing the course of the newly diagnosed AF after stroke. We have assumed that if AF was persistent or recurrent after the acute phase of stroke, this arrhythmia was more likely to be a primary cardiac event rather than a consequence of the acute stroke.
Among the 21 subjects in whom AF was documented for the first time on stroke admission, more than half (12/21) were in chronic AF, ie, AF persisted from the first documentation. Even if the AF was paroxysmal initially (9/21), most of these subjects (7/9) had recurrence of paroxysms or transition to chronic AF. If we exclude the five in-hospital fatal subjects whose information regarding the course of AF might be limited by the short observation period (within 3 to 25 days), 15 of 16 subjects who survived the first month after stroke continued to have this rhythm disturbance. In subjects who remained in AF after the acute phase of stroke, it seemed likely that AF led to rather than resulted from the stroke.
It is notable that one of the two persons with transient AF only, who was followed for nearly 3 years, was the only subject presenting with intracerebral hemorrhage among the stroke subjects with newly diagnosed AF. As described above, a predominance of primary cerebral hemorrhage was seen in the series of Vingerhoets et al.13 Since primary intracranial hemorrhage is not likely to be precipitated by AF, the newly discovered AF may have a different significance for subjects with ischemic stroke and those with hemorrhagic stroke. The question of whether common vascular disorders lead to AF and to intracranial hemorrhage independently or the hemorrhage predisposes to AF remains to be elucidated by further physiological study and clinicopathologic correlation.
In the five subjects in whom sinus rhythm was recorded on admission but AF appeared 2 to 14 days after the onset of stroke, AF might not directly account for the stroke. In contrast to the finding in the study of Vingerhoets et al13 that AF disappeared after a few days in 16 of 17 persons with AF after admission, the arrhythmia in our subjects was either persistent from the very onset or recurrent in later course. In subjects who developed AF soon after stroke onset, AF might be a manifestation of coexistent cardiovascular diseases instead of a consequence of stroke.
Strengths and Limitations
All these subjects were derived from a population sample under
prospective long-term follow-up and systematic medical surveillance.
The population basis and availability of accurate information of the
prestroke and poststroke cardiovascular conditions in
stroke subjects enabled us to clarify the natural history of AF with
less selection bias than most of the hospital-based series.
Unfortunately, the number of cases in this study was small.
Furthermore, the accuracy of classification of AF is certainly affected
by the length and intensity of follow-up. A portion of our subjects
(6/26) with newly discovered AF died shortly after stroke onset (within
3 to 25 days), which inherently weakened the ascertainment of the
course of AF. For those who survived the acute stage, we followed the
course of AF by tracing all medical details surrounding the interim
hospitalizations as well as biennial routine examinations.
Nevertheless, without continuous ECG monitoring, misclassification of
the type of AF could have happened; in particular, some paroxysms of AF
might not be detected, and accordingly we might overestimate the
frequency of "transient AF." Despite this potential error of
classification, because of the small number of transient AF subjects in
our study, the main finding is unlikely to be altered.
In conclusion, our study showed that 92% (24/26) of the newly discovered AF at acute stroke was sustained or recurred after the acute stage. While we cannot state definitively that the AF was present before the onset of stroke and precipitated the stroke, our follow-up data wherein most of the subjects remained in AF suggest that the newly documented AF seemed more likely to be a primary cardiac event, with or without precipitating the stroke, rather than a transient consequence of acute stroke. In addition to the substantial risk of thromboembolism associated with AF, subjects with AF who have had one or more embolic events are at high risk of further emboli.27 The previous report of the Framingham Study10 also indicated that recurrence after initial stroke occurred early and sooner in persons with AF. Most subjects with newly diagnosed AF at the time of nonhemorrhagic stroke should be strongly considered for anticoagulant therapy.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received April 25, 1995; revision received June 9, 1995; accepted June 9, 1995.
| References |
|---|
|
|
|---|
2.
Cardiogenic brain embolism: the second report
of the Cerebral Embolism Task Force. Arch Neurol. 1989;46:727-743.
3.
Wolf PA, Abbott RD, Kannel WB. Atrial
fibrillation: a major contributor to stroke in the elderly: the
Framingham Study. Arch Intern Med. 1987;147:1561-1564.
4.
Britton M, Gustafsson C. Non-rheumatic atrial
fibrillation as a risk factor for stroke. Stroke. 1985;16:182-188.
5.
Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB.
Epidemiologic assessment of chronic atrial fibrillation and risk
of stroke: the Framingham Study. Neurology. 1978;28:973-977.
6.
Friedman GD, Loveland DB, Ehrlich SP Jr.
Relationship of stroke to other cardiovascular
disease. Circulation. 1968;38:533-541.
7.
Tanaka H, Hayashi M, Date C, Imai K, Asada M, Shoji H,
Okazaki K, Yamamoto H, Yoshikawa K, Shimada T, Lee SI.
Epidemiologic studies of stroke in Shibata, a Japanese
provincial city: preliminary report on risk factors for cerebral
infarction. Stroke. 1985;16:773-780.
8.
Petersen P, Godtfredsen J. Embolic
complications in paroxysmal atrial fibrillation.
Stroke. 1986;17:622-626.
9.
Sherman DG, Goldman L, Whiting RB, Jurgensen K, Kaste
M, Easton JD. Thromboembolism in patients with atrial
fibrillation. Arch Neurol. 1984;41:708-710.
10.
Wolf PA, Kannel WB, McGee DL, Meeks SL, Bharucha NE,
McNamara PM. Duration of atrial fibrillation and imminence of
stroke: the Framingham Study. Stroke. 1983;14:664-667.
11. Corbalan R, Arriagada D, Braun S, Tapia J, Huete I, Kramer A, Chavez A. Risk factors for systemic embolism in patients with paroxysmal atrial fibrillation. Am Heart J. 1992;124:149-153. [Medline] [Order article via Infotrieve]
12.
Petersen P. Thromboembolic complications in
atrial fibrillation. Stroke. 1990;21:4-13.
13.
Vingerhoets F, Bogousslavsky J, Regli F, Van Melle G.
Atrial fibrillation after acute stroke.
Stroke. 1993;24:26-30.
14. Shurtleff D. Some characteristics related to the incidence of cardiovascular disease and death: Framingham Study, 18 year follow-up. In: Kannel WB, Gordon T, eds. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Washington, DC: Dept of Health, Education, and Welfare; 1974:section 30. DHEW publication NIH 74-599.
15. Godtfredsen J. Atrial fibrillation: course and prognosis: a follow-up study of 1212 cases. In: Kulbertus HE, Olsson SB, Schlepper M, eds. Atrial Fibrillation. Molndal, Sweden: A Lindgren & Soner AB; 1982:134-147.
16. Yamour BJ, Sridharan MR, Rice JF, Flowers NC. Electrocardiographic changes in cerebrovascular hemorrhage. Am Heart J. 1980;99:294-300. [Medline] [Order article via Infotrieve]
17.
Mikolich JR, Jacobs WC, Fletcher GF. Cardiac
arrhythmias in patients with acute cerebrovascular
accidents. JAMA. 1981;246:1314-1317.
18.
Goldstein DS. The
electrocardiogram in stroke: relationship to
pathophysiological type and comparison with
prior tracings. Stroke. 1979;10:253-259.
19.
Dimant J, Grob D. Electrocardiographic changes
and myocardial damage in patients with acute cerebrovascular
accidents. Stroke. 1977;8:448-455.
20.
Norris JW, Froggatt GM, Hachinski VC. Cardiac
arrhythmias in acute stroke. Stroke. 1978;9:392-396.
21.
Rem JA, Hachinski VC, Boughner DR, Barnett HJM.
Value of cardiac monitoring and
echocardiography in TIA and stroke
patients. Stroke. 1985;16:950-956.
22.
Lavy S, Yaar I, Melamed E, Stern S. The effect
of acute stroke on cardiac functions as observed in an intensive stroke
care unit. Stroke. 1974;5:775-780.
23.
Andreoli A, di Pasquale G, Pinelli G, Grazi P, Tognetti
F, Testa C. Subarachnoid hemorrhage: frequency
and severity of cardiac arrhythmias: a survey of 70 cases
studied in the acute phase. Stroke. 1987;18:558-564.
24. Stober T, Anstatt T, Sen S, Schimrigk K, Jager H. Cardiac arrhythmias in subarachnoid haemorrhage. Acta Neurochir (Wien). 1988;93:37-44. [Medline] [Order article via Infotrieve]
25.
Eisalo A, Perasalo J, Halonen PI.
Electrocardiographic abnormalities and some laboratory findings
in patients with subarachnoid haemorrhage.
Br Heart J. 1972;34:217-226.
26. Shuster S. The electrocardiogram in subarachnoid haemorrhage. Br Heart J. 1960;22:316-320.
27.
Flegel KM, Hanley J. Risk factors for stroke and
other embolic events in patients with nonrheumatic atrial
fibrillation. Stroke. 1989;20:1000-1004.
This article has been cited by other articles:
![]() |
T. Miyairi, S. Miura, I. Kigawa, H. Yamauchi, S. Fukuda, S. Yachi, and K. Hara Mid-term results of a closed biatrial procedure using bipolar radiofrequency ablation concomitantly performed with non-mitral cardiac operations Interactive CardioVascular and Thoracic Surgery, August 1, 2009; 9(2): 169 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Z. Soliman, R. J. Prineas, L. D. Case, Z.-m. Zhang, and D. C. Goff Jr Ethnic Distribution of ECG Predictors of Atrial Fibrillation and Its Impact on Understanding the Ethnic Distribution of Ischemic Stroke in the Atherosclerosis Risk in Communities (ARIC) Study Stroke, April 1, 2009; 40(4): 1204 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Camm, P. Kirchhof, G. Y.H. Lip, I. Savelieva, and S. Ernst CHAPTER 29 Atrial Fibrillation ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Q. Cui, L. B. Sun, Y. Li, C. L. Xu, J. Han, H. Li, and X. Meng Intraoperative Modified Cox Mini-Maze Procedure for Long-Standing Persistent Atrial Fibrillation Ann. Thorac. Surg., April 1, 2008; 85(4): 1283 - 1289. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liao, Z. Khalid, C. Scallan, C. Morillo, and M. O'Donnell Noninvasive Cardiac Monitoring for Detecting Paroxysmal Atrial Fibrillation or Flutter After Acute Ischemic Stroke: A Systematic Review Stroke, November 1, 2007; 38(11): 2935 - 2940. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Abboud, J. Labreuche, F. Gongora-Riverra, A. Jaramillo, C. Duyckaerts, P. G. Steg, J.-J. Hauw, and P. Amarenco Prevalence and Determinants of Subdiaphragmatic Visceral Infarction in Patients With Fatal Stroke Stroke, May 1, 2007; 38(5): 1442 - 1446. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Wolf, E. W. Schneeberger, R. Osterday, D. Miller, W. Merrill, J. B. Flege Jr, and A. M. Gillinov Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 797 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Jabaudon, J. Sztajzel, K. Sievert, T. Landis, and R. Sztajzel Usefulness of Ambulatory 7-Day ECG Monitoring for the Detection of Atrial Fibrillation and Flutter After Acute Stroke and Transient Ischemic Attack Stroke, July 1, 2004; 35(7): 1647 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Page, T. W. Tilsch, S. J. Connolly, D. J. Schnell, S. R. Marcello, W. E. Wilkinson, E. L.C. Pritchett, and for the Azimilide Supraventricular Arrhythmia Prog Asymptomatic or "Silent" Atrial Fibrillation: Frequency in Untreated Patients and Patients Receiving Azimilide Circulation, March 4, 2003; 107(8): 1141 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hou, D. Osei-Hyiaman, H. Yu, Z. Ren, Z. Zhang, B. Wang, and S. Harada Association of a 27-bp repeat polymorphism in ecNOS gene with ischemic stroke in Chinese patients Neurology, February 27, 2001; 56(4): 490 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wiesel Cost-Effectiveness of Therapy in Nonatrial Fibrillation Ann Intern Med, December 21, 1999; 131(12): 979 - 979. [Full Text] [PDF] |
||||
![]() |
E. Catherwood and M. L. Greenberg Cost-Effectiveness of Therapy in Nonatrial Fibrillation Ann Intern Med, December 21, 1999; 131(12): 979 - 979. [Full Text] [PDF] |
||||
![]() |
H. S. Jorgensen, H. Nakayama, J. Reith, H. O. Raaschou, and T. S. Olsen Acute Stroke With Atrial Fibrillation: The Copenhagen Stroke Study Stroke, October 1, 1996; 27(10): 1765 - 1769. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |